EBMT 2019 | Inhibiting the JAK pathway to prevent GvHD

John DiPersio

Here, John DiPersio, MD, PhD, of Washington University School of Medicine, St. Louis, MO, talks about JAK pathway inhibitors for the treatment and prevention of graft-versus-host disease. Dr DiPersio was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video